Learn more

BEIJING JIFULIN BIOTECHNOLOGY CO LTD

Overview
  • Total Patents
    15
About

BEIJING JIFULIN BIOTECHNOLOGY CO LTD has a total of 15 patent applications. Its first patent ever was published in 2009. It filed its patents most often in China. Its main competitors in its focus markets biotechnology, agriculture and pharmaceuticals are DNX CORP, PPL THERAPEUTICS SCOTLAND LTD and TRANXENOGEN INC.

Patent filings in countries

World map showing BEIJING JIFULIN BIOTECHNOLOGY CO LTDs patent filings in countries
# Country Total Patents
#1 China 15

Patent filings per year

Chart showing BEIJING JIFULIN BIOTECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Li Ning 11
#2 Tang Bo 9
#3 Wang Jianwu 4
#4 Ning Li 3
#5 Fang Rui 2
#6 Bo Tang 2
#7 Ding Fangrong 2
#8 Zhao Jianmin 2
#9 Zhang Lei 2
#10 Chang Fei 2

Latest patents

Publication Filing date Title
CN103725711A Expression vector for specifically expressing Follistatin-317 of porcine muscles and application of vector
CN103725710A Self-deleting free carrier and application thereof
CN103709246A Purification method for lactoferrin and lactoperoxidase
CN104651397A Porcine muscle amicine gene targeting carrier and application thereof
CN103524621A Anti-human CD20 chimeric monoclonal antibody
CN104513305A Purification method for whey protein
CN103088000A Method for overexpression of cholate activation lipase in mammary gland of mammal
CN102766206A Product for improving iron deficiency anemia and preparation method thereof
CN102628060A Production method of low-fat milk
CN102212545A Method for knocking out cattle beta-lactoglobulin gene by using zinc finger nucleases (ZFNs)
CN102199624A Method for efficiently producing recombinant proteins in mammary glands by utilizing artificial chromosomes
CN102115731A Method for preparing porcine reproductive and respiratory syndrome resistant transgenic pig
CN102080101A Targeted exogenous gene integration method
CN101955961A Gene knockout targeting vector and application thereof
CN101886082A Method for producing humanized monoclonal antibody using animal mammary gland bioreactor